Current Issue Volume 23(2); April 2025
Intestinal Research

Latest Issue: Volume 23 Issue 2
Editor-in-Chief: Toshifumi Hibi
Print ISSN: 1598-9100
Online ISSN: 2288-1956
Online ISSN: 2288-1956
Frequency: Quarterly
Impact Factor: 3.9
Gastroenterology & Hepatology - Q2 (38/147)
Impact Factor: 3.9
Gastroenterology & Hepatology - Q2 (38/147)

- MOST CITED
-
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis44
- Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease35
- Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease29
- Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer24
- MOST VIEWED
-
- Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease12,588
- Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis12,115
- Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases9,948
- Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer9,754
- AHEAD OF PRINT
-
- Ulcerative colitis disease severity affects the speed of symptom relief under filgotinib treatment: a post hoc analysis of the phase 2b/3 SELECTION study
- A real-world comparison of subcutaneous to intravenous administration of infliximab in patients with inflammatory bowel disease
- Evolution of inflammatory bowel disease in Korea: a 60-year perspective on clinical and research development
- Comparative effectiveness of ustekinumab versus infliximab in the management of perianal fistulizing Crohn's disease: a retrospective study in China